Skip to main content
Log in

Safe and effective hyposensitization in bakers suffering from year-round allergic rhinoconjunctivitis and allergic bronchial asthma caused by flour dust allergy

  • original article
  • Published:
Allergo Journal International Aims and scope Submit manuscript

Abstract

Background

The inhalation of flour dust increases the risk of allergic obstructive respiratory disease in bakers. Therefore, flour-induced bronchial asthma is one of the most common work-related respiratory diseases, the symptoms of which often lead to disability.

Methods

Since 2002, 39 patients with flour-induced allergic rhinoconjunctivitis and baker’s asthma have undergone hyposensitization in the author’s department using specific immunotherapy (SIT) with a flour mixture. In addition, 10 cases of treatment failure were treated for a further 5 years with a dual therapy consisting of causal SIT and symptomatic treatment using the anti-IgE antibody omalizumab.

Results

SIT- and dual-treated patients showed a marked improvement in nasal, conjunctival, and bronchial symptoms. No severe local or systemic side effects were observed.

Conclusion

Both SIT and dual therapy represent an effective and well-tolerated treatment option in flour dust-allergic individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

FEV1:

Forced expiratory volume in 1 s

IgE:

Immunoglobulin E

MAE11:

Monoclonal mouse antibody

NPT:

Nasal provocation test

rhuMAb-E25:

Humanized, monoclonal anti-IgE antibodies

SCIT:

Subcutaneous immunotherapy

SIT:

Specific immunotherapy

VAS:

Visual analog scales

References

  1. Saak A. Unser täglich Brot … Segen oder Gefährdung? Allergiker. 1993;4:8–11.

    Google Scholar 

  2. Sander I, Raulf-Heimsoth M. Ursachen des Bäckerasthmas auf der Spur. Neue Methoden zur Ermittlung des Sensibilisierungsprofils. IPA J. 2011;2:20–1.

    Google Scholar 

  3. Schönberger A, Mehrtens G, Valentin H, editors. Arbeitsunfall und Berufskrankheit. Rechtliche und Medizinische Grundlagen für Gutachter, Sozialverwaltung, Berater und Gerichte. Berlin: Erich Schmidt; 1993.

    Google Scholar 

  4. Straube M, Szliska C, Schwanitz HJ. Allergene und Irritanzien im Bäckerhandwerk. Allergologie. 1996;19:494–9.

    Google Scholar 

  5. Nahrungsmittel-Kontaktallergie bei Bäckern und Konditoren. Umwelt- und berufsdermatologischer Bulletin, Fa. Asche AG, ed. 1997;67

  6. Quirce S, Diaz-Perales A. Diagnosis and management of grain-induced asthma. Allergy Asthma Immunol Res. 2013;5:348–56.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nemat K, Henker J. Glutenintoleranz. Weizenallergie, Zöliakie, Glutensensitivität. Arztebl Sachsen. 2014;1:27–9.

    Google Scholar 

  8. Raulf-Heimsoth M, van Kampen V, Kespohl S, Sander I, Merget R, Brüning T. Inhalationsallergien am Arbeitsplatz. Aktuelle Entwicklungen. Bundesgesundheitsblatt. 2012;55:363–72.

    Article  CAS  Google Scholar 

  9. Sander I, Raulf-Heimsoth M, Düser M, Flagge A, Czuppon AB, Baur X. Differentiation between cosensitization and cross-reactivity of wheat flour and grass pollen allergens. Int Arch Allergy Immunol. 1997;112:378–85.

    Article  CAS  PubMed  Google Scholar 

  10. Tasman AJ, Witzel A, Simonis B, Sohmen R, Grieshaber R, Heppt W. Prick-Test und nasaler Provokationstest mit individuellen Mehlextrakten bei Bäckerrhinitis. HNO. 1999;47:718–22.

    Article  CAS  PubMed  Google Scholar 

  11. Kniel B, Würth C. Allergien in Zusammenhang mit Backwaren und deren Herstellung – ein Diskussionsbeitrag. Inf Backmittelinst. 1996;22:1–8.

    Google Scholar 

  12. Olivieri M, Biscardo CA, Turri S, Perbellini L. Omalizumab in persistent severe baker’s asthma. Allergy. 2008;63:790–1.

    Article  CAS  PubMed  Google Scholar 

  13. Kanerva L, Vaheri E. Occupational allergic rhinitis in Finland. Int Arch Occup Environ Health. 1993;64:565–8.

    Article  CAS  PubMed  Google Scholar 

  14. Houba R, Doekes G, Heederik D. Occupational respiratory allergy in bakery workers: a review of the literature. Am J Ind Med. 1998;34:529–46.

    Article  CAS  PubMed  Google Scholar 

  15. Baur X, Sander I, Jansen A, Czuppon AB. Are amylases in bakery products and flour potential food allergens? Schweiz Med Wochenschr. 1994;124:846–51.

    CAS  PubMed  Google Scholar 

  16. Fränken J, Ulmer WT, Altmeyer P, Stephan U, Das Bäckerasthma KW. Auslösende Allergene und der Einfluss von Hauptallergenen auf immunmodulatorische Vorgänge in vitro. Allergologie. 1993;16:83–6.

    Google Scholar 

  17. Pahr S, Constantin C, Papadopoulos NG, Giavi S, Mäkelä M, Pelkonen A, et al. α‑Purothionin, a new wheat allergen associated with severe allergy. J Allergy Clin Immunol. 2013;132(4):1000–1003.e4.

    Article  CAS  PubMed  Google Scholar 

  18. Simonis B, Sohmen R, Grün L, Heimbüchel G, Grieshaber R. alpha-Amylase-Exposition bei sensibilisierten und nichtsensibilisierten Bäckern mit obstruktiven allergischen Atemwegserkrankungen. Allergo J. 1998;7:425–30.

    Google Scholar 

  19. Baur X, Sander I. Allergien auf Getreidelebensmittel einschließlich Backmittel, Getreide, Mehl und Brot. Inf Backmittelinst. 1995;49:58–61.

    Google Scholar 

  20. Baur X, Chen Z, Sander I. Isolation and denomination of an important allergen in baking additives: alpha-amylase from Aspergillus oryzae (Asp o II). Clin Exp Allergy. 1994;24:465–70.

    Article  CAS  PubMed  Google Scholar 

  21. Sander I, Rozynek P, Rihs HP, van Kampen V, Chew FT, Lee WS, et al. Multiple wheat flour allergens and cross-reactive carbohydrate determinants bind IgE in baker’s asthma. Allergy. 2011;66:1208–15.

    Article  CAS  PubMed  Google Scholar 

  22. bmi aktuell. Informationen aus dem Backmittelinstitut 2001;2

  23. Ring J, Bachert C, Bauer C‑P, Czech W, editors. Weißbuch Allergie in Deutschland. München: Springer; 2010. pp. 17–9.

    Google Scholar 

  24. Braun E. Mehl, das nicht den Atem nimmt. BGN Akzente. 2011. http://www.bgn.de/464/35532?wc_origin=%2F10331%3Fsk%3D2736%26page%3D&wc_mb=WC.

    Google Scholar 

  25. Vermeidung von Bäckerasthma. In: Arbeits-Sicherheits-Informationen der BGN. ASI 8.80 [vorschriften.portal.bgn.de/9427]

  26. Hytönen M, Sala E. Nasal provocation test in the diagnostics of occupational allergic rhinitis. Rhinology. 1996;34:86–90.

    PubMed  Google Scholar 

  27. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, et al. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J. 2002;11:29–36.

    Google Scholar 

  28. Hauswald B, Yarin YM. Moderne Diagnostik und Therapie der Rhinitis allergica. Laryngorhinootologie. 2015;94:331–45.

    Article  CAS  PubMed  Google Scholar 

  29. Wedi B. Stellenwert und Indikation der SLIT im Vergleich zur SCIT. Hautarzt. 2008;59:537–43.

    Article  CAS  PubMed  Google Scholar 

  30. Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Kunkel G, Lepp U, et al. Spezifische Immuntherapie bei IgE vermittelten allergischen Atemwegserkrankungen. Dtsch Arztebl. 2003;100:A 334–A 9.

    Google Scholar 

  31. Mösges R. Is classical immunotherapy dead? Curr Opin Allergy Clin Immunol. 2010;10:167.

    Article  PubMed  Google Scholar 

  32. Armentia A, Martin-Santos JM, Quintero A, Fernandez A, Barber D, Alonso E, et al. Baker’s asthma: prevalence and evaluation of immunotherapy with a wheat flour extract. Ann Allergy. 1990;65:265–72.

    CAS  PubMed  Google Scholar 

  33. Swaminathan S, Heddle JR. Wheat flour immunotherapy in baker’s asthma. Intern Med J. 2007;37:663–4.

    Article  CAS  PubMed  Google Scholar 

  34. Brown SG, Wiese MD, van Eeden P, Stone SF, Chuter CL, Gunner J, et al. Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial. J Allergy Clin Immunol. 2012;130:162–8.

    Article  PubMed  Google Scholar 

  35. Cirla AM, Lorenzini RA, Cirla PE. Specific immunotherapy and relocation in occupational allergic bakers. G Ital Med Lav Ergon. 2007;29(3 Suppl):443–5.

    CAS  PubMed  Google Scholar 

  36. Pérez Pimiento A, Buesco Fernández A, García LJ, Rodríguez Cabreros MI, et al. Effect of omalizumab treatment in a baker with occupational asthma. J Investig Allergol Clin Immunol. 2008;18:490–1.

    PubMed  Google Scholar 

  37. Brown R, Turk F, Dale P, Bousquet J. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy. 2007;62:149–53.

    Article  CAS  PubMed  Google Scholar 

  38. Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE zur Behandlung der Rhinitis allergica – und der Polyposis nasi? Allergologie. 2007;30:338–54.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bettina Hauswald.

Ethics declarations

Conflict of interest

B. Hauswald, M. Cuevas, J. Boxberger and T. Zahnert declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hauswald, B., Cuevas, M., Boxberger, J. et al. Safe and effective hyposensitization in bakers suffering from year-round allergic rhinoconjunctivitis and allergic bronchial asthma caused by flour dust allergy. Allergo J Int 27, 43–48 (2018). https://doi.org/10.1007/s40629-018-0052-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40629-018-0052-4

Keywords

Navigation